Fred Alger Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-182,765
| Closed | -$2.71M | – | 451 |
|
|
2024
Q1 | $2.71M | Buy |
+182,765
| New | +$2.71M | 0.01% | 319 |
|
|
2021
Q1 | – | Sell |
-18,822
| Closed | -$873K | – | 495 |
|
|
2020
Q4 | $873K | Sell |
18,822
-12,485
| -40% | -$579K | ﹤0.01% | 378 |
|
|
2020
Q3 | $1.03M | Sell |
31,307
-36,295
| -54% | -$1.2M | ﹤0.01% | 343 |
|
|
2020
Q2 | $1.86M | Buy |
67,602
+44,602
| +194% | +$1.22M | 0.01% | 311 |
|
|
2020
Q1 | $689K | Sell |
23,000
-22,000
| -49% | -$659K | ﹤0.01% | 343 |
|
|
2019
Q4 | $1.25M | Sell |
45,000
-43,000
| -49% | -$1.19M | ﹤0.01% | 323 |
|
|
2019
Q3 | $1.6M | Sell |
88,000
-17,000
| -16% | -$309K | 0.01% | 295 |
|
|
2019
Q2 | $2.58M | Buy |
105,000
+10,000
| +11% | +$245K | 0.01% | 283 |
|
|
2019
Q1 | $903K | Buy |
+95,000
| New | +$903K | ﹤0.01% | 340 |
|
|
2018
Q3 | – | Sell |
-8,000
| Closed | -$102K | – | 561 |
|
|
2018
Q2 | $102K | Buy |
+8,000
| New | +$102K | ﹤0.01% | 392 |
|